Christine Hann

Associate Professor

19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Christine Hann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
HhAntag691 Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Camptothecin Medicine & Life Sciences
Type I DNA Topoisomerase Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

Dynamics of tumor and immune responses during immune checkpoint blockade in non–small cell lung cancer

Anagnostou, V., Forde, P., White, J. R., Niknafs, N., Hruban, C., Naidoo, J., Marrone, K., Ashok Sivakumar, I. K., Bruhm, D. C., Rosner, S., Phallen, J., Leal, A., Adleff, V., Smith, K., Cottrell, T. R., Rhymee, L., Palsgrove, D. N., Hann, C., Levy, B., Feliciano, J. & 16 others, Georgiades, C. S., Verde, F., Illei, P. B., Li, Q. K., Gabrielson, E., Brock, M. V., Isbell, J. M., Sauter, J. L., Taube, J. M., Scharpf, R. B., Karchin, R., Pardoll, A. M., Chaft, J. E., Hellmann, M. D., Brahmer, J. & Velculescu, V. E., Jan 1 2019, In : Cancer Research. 79, 6, p. 1214-1225 12 p.

Research output: Contribution to journalArticle

Open Access
Non-Small Cell Lung Carcinoma
DNA
Neoplasms
Therapeutics
Confidence Intervals

Lung cancer and family-centered concerns

Feliciano, J., Chang, A., Venkatraman, D., Brooks, S., Zagaja, C., Ettinger, D. S., Hann, C., Naidoo, J., Voong, K., Hales, R., Turner, M., Peterson, V. & Bodurtha, J. N., Jan 1 2019, In : Supportive Care in Cancer.

Research output: Contribution to journalArticle

Lung Neoplasms
Focus Groups
Caregivers
Neoplasms
Family Health
Non-Small Cell Lung Carcinoma
Pneumonia
Radiotherapy
Thorax
Ligands
Metformin
Carboplatin
Paclitaxel
Non-Small Cell Lung Carcinoma
Drug Therapy

Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma

Gallia, G. L., Zhang, M., Ning, Y., Haffner, M. C., Batista, D., Binder, Z. A., Bishop, J. A., Hann, C., Hruban, R. H., Ishii, M., Klein, A., Reh, D. D., Rooper, L., Salmasi, V., Tamargo, R. J., Wang, Q., Williamson, T., Zhao, T., Zou, Y., Meeker, A. K. & 5 others, Agrawal, N., Vogelstein, B., Kinzler, K. W., Papadopoulos, N. & Bettegowda, C., Dec 1 2018, In : Nature Communications. 9, 1, 5410.

Research output: Contribution to journalArticle

Olfactory Esthesioneuroblastoma
deletion
Dystrophin
Genes
genes